|
1
|
Siegel RL, Miller KD and Jemal A: Cancer statistics, 2020. CA Cancer J Clin. 70:7–30. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ and Members P: Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St. Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 22:1736–1747. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A, Martiat P, Fox SB, Harris AL and Liu ET: Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA. 100:10393–10398. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu B, Wang T, Wang H, Zhang L, Xu F, Fang R, Li L, Cai X, Wu Y, Zhang W and Ye L: Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer. J Hematol Oncol. 11:262018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), . Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet. 365:1687–1717. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bykov VJN, Eriksson SE, Bianchi J and Wiman KG: Targeting mutant p53 for efficient cancer therapy. Nat Rev Cancer. 18:89–102. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
De Camilli P, Chen H, Hyman J, Panepucci E, Bateman A and Brunger AT: The ENTH domain. FEBS Lett. 513:11–18. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song K, Wu H, Rahman HN, Dong Y, Wen A, Brophy ML, Wong S, Kwak S, Bielenberg DR and Chen H: Endothelial epsins as regulators and potential therapeutic targets of tumor angiogenesis. Cell Mol Life Sci. 74:393–398. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang Y, Song W, Kan P, Huang C, Ma Z, Wu Q, Yao X and Zhang B: Overexpression of Epsin 3 enhances migration and invasion of glioma cells by inducing epithelial-mesenchymal transition. Oncol Rep. 40:3049–3059. 2018.PubMed/NCBI
|
|
10
|
Mori J, Tanikawa C, Ohnishi N, Funauchi Y, Toyoshima O, Ueda K and Matsuda K: EPSIN 3, a novel p53 target, regulates the apoptotic pathway and gastric carcinogenesis. Neoplasia. 19:185–195. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schiano Lomoriello I, Giangreco G, Iavarone C, Tordonato C, Caldieri G, Serio G, Confalonieri S, Freddi S, Bianchi F, Pirroni S, et al: A self-sustaining endocytic-based loop promotes breast cancer plasticity leading to aggressiveness and pro-metastatic behavior. Nat Commun. 11:30202020. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Subramaniyan B, Sridharan S, Howard CM, Tilley AMC, Basuroy T, de la Serna I, Butt E and Raman D: Role of the CXCR4-LASP1 axis in the stabilization of snail1 in triple-negative breast cancer. Cancers (Basel). 12:23722020. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun Q, Fan G, Zhuo Q, Dai W, Ye Z, Ji S, Xu W, Liu W, Hu Q, Zhang Z, et al: Pin1 promotes pancreatic cancer progression and metastasis by activation of NF-κB-IL-18 feedback loop. Cell Prolif. 53:e128162020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feng X, Xu X, Xiao X, Zou K, Yu W, Wu J, Tang R, Gao Y, Hao J, Zhao X, et al: NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer. Cell Death Dis. 8:e27832017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jar AM: Animal welfare and the use of laboratory animals in scientific research. Rev Argent Microbiol. 46:77–79. 2014.(In Spanish). PubMed/NCBI
|
|
16
|
Feng J, Wen T, Li Z, Feng L, Zhou L, Yang Z, Xu L, Shi S, Hou K, Shen J, et al: Cross-talk between the ER pathway and the lncRNA MAFG-AS1/miR-339-5p/CDK2 axis promotes progression of ER+ breast cancer and confers tamoxifen resistance. Aging (Albany NY). 12:20658–20683. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Hellwig B, Madjar K, Edlund K, Marchan R, Cadenas C, Heimes AS, Almstedt K, Lebrecht A, Sicking I, Battista MJ, et al: Epsin family member 3 and ribosome-related genes are associated with late metastasis in estrogen receptor-positive breast cancer and long-term survival in non-small cell lung cancer using a genome-wide identification and validation strategy. PLoS One. 11:e1675852016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Spradling KD, McDaniel AE, Lohi J and Pilcher BK: Epsin 3 is a novel extracellular matrix-induced transcript specific to wounded epithelia. J Biol Chem. 276:29257–29267. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ko G, Paradise S, Chen H, Graham M, Vecchi M, Bianchi F, Cremona O, Di Fiore PP and De Camilli P: Selective high-level expression of epsin 3 in gastric parietal cells, where it is localized at endocytic sites of apical canaliculi. Proc Natl Acad Sci USA. 107:21511–21516. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kohn KW, Zeeberg BM, Reinhold WC and Pommier Y: Gene expression correlations in human cancer cell lines define molecular interaction networks for epithelial phenotype. PLoS One. 9:e992692014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nagano T, Nakano M, Nakashima A, Onishi K, Yamao S, Enari M, Kikkawa U and Kamada S: Identification of cellular senescence-specific genes by comparative transcriptomics. Sci Rep. 6:317582016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Coon BG, Burgner J, Camonis JH and Aguilar RC: The epsin family of endocytic adaptors promotes fibrosarcoma migration and invasion. J Biol Chem. 285:33073–33081. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arden N and Betenbaugh MJ: Life and death in mammalian cell culture: Strategies for apoptosis inhibition. Trends Biotechnol. 22:174–180. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chang H, Li J, Qu K, Wan Y, Liu S, Zheng W, Zhang Z and Liu C: CRIF1 overexpression facilitates tumor growth and metastasis through inducing ROS/NFκB pathway in hepatocellular carcinoma. Cell Death Dis. 11:3322020. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Leo R, Therachiyil L, Siveen SK, Uddin S, Kulinski M, Buddenkotte J, Steinhoff M and Krishnankutty AR: Protein expression profiling identifies key proteins and pathways involved in growth inhibitory effects exerted by guggulsterone in human colorectal cancer cells. Cancers (Basel). 11:14782019. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Song K, Cai X, Dong Y, Wu H, Wei Y, Shankavaram UT, Cui K, Lee Y, Zhu B, Bhattacharjee S, et al: Epsins 1 and 2 promote NEMO linear ubiquitination via LUBAC to drive breast cancer development. J Clin Invest. 131:e1293742021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Frasor J, El-Shennawy L, Stender JD and Kastrati I: NFκB affects estrogen receptor expression and activity in breast cancer through multiple mechanisms. Mol Cell Endocrinol. 418(Pt 3): 235–239. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Smart E, Semina SE and Frasor J: Update on the role of NFκB in promoting aggressive phenotypes of estrogen receptor-positive breast cancer. Endocrinology. 161:bqaa1522020. View Article : Google Scholar : PubMed/NCBI
|
